BRKR News and Press, Bruker Corporation

The new platform delivers unmatched quantitation, robustness, and throughput to support clinical translation of spatial proteomics assays Bruker Corporation (Nasdaq: BRKR) announced the launch of CellScape™ XR, a next-generation spatial proteomics platform designed to adv...

Bruker Spatial Biology, a division of Bruker Corporation (Nasdaq: BRKR) announced today that it will expand its collaboration with Noetik Inc., following their prior study of more than 3500 patient samples with the CosMx ® Spatial Molecular Imager (SMI). CosMx SMI powers Noetik's pre...

Novel timsOmni™ workflows enable deeper functional characterization of proteoforms and PTMs, leveraging multi-stage, ultra-sensitive trapped eXd molecular fragmentation Bruker ProteoScape™ expands AI‑enhanced de novo peptide sequencing for complex samples ...

Portfolio innovations include the launch of the new CellScape XR spatial proteomics platform, the unique CosMx mouse whole transcriptome panel, the launch of the PaintScape platform for 3D genome visualization, extensive multiomics GeoMx capabilities, and AI-ready AtoMx analysis B...

2026-02-12 15:04:10 ET from Jefferies issued a price target of $50.00 for BRKR on 2026-02-12 19:24:31. The adjusted price target was set to $50.00. At the time of the announcement, BRKR was trading at $37.51. The overall price target consensus is at $53.00 with high pric...

2026-02-12 13:35:18 ET More on Bruker Bruker Corporation (BRKR) Q4 2025 Earnings Call Transcript Bruker Corporation (BRKR) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Bruker Corporation (BRKR) Presents at 44th Annual J.P. Morgan Healthcare C...

2026-02-12 13:34:24 ET Bruker Corporation (BRKR) Q4 2025 Earnings Call February 12, 2026 8:30 AM EST Company Participants Joe Kostka Frank Laukien - Chairman, CEO & President Gerald Herman - Executive VP & CFO ... Read the full article on Seeking ...

2026-02-12 11:21:24 ET Image source: The Motley Fool. Thursday, Feb. 12, 2026 at 8:30 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-02-12 07:08:54 ET More on Bruker Bruker Corporation (BRKR) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Bruker Corporation (BRKR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Bruker: Attractive Valuation Ahead Of ...

Q4-25 revenues of $977.2 million, flat year-over-year (yoy), down ~5% organically Q4-25 GAAP diluted earnings per share (EPS) of $0.10; non-GAAP diluted EPS of $0.59 FY25 revenues of $3.44 billion, up ~2% yoy, down ~4% organically FY25 GAAP diluted loss per share of $(0.15...